Biocon Investor Relations Material
Latest events
Q4 24/25
Biocon
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Biocon Ltd
Access all reports
Biocon Limited operates through Biologics, Branded Formulations, and Research Services segments. The Biologics segment sells pharmaceutical products and services to regulated markets, including India and United States; the India market through alliance partners and sale of clinical trial material; various countries in Asia Pacific and Middle East and Africa through alliance partners; and the Europe market through its subsidiary Biocon Norway. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.
Key slides for Biocon Ltd
Q3 24/25
Biocon Ltd
Q2 24/25
Biocon Ltd
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
BIOCON
Country
🇮🇳 India